company background image
SBRA

Sabra Health Care REIT NasdaqGS:SBRA Stock Report

Last Price

US$14.67

Market Cap

US$3.4b

7D

4.6%

1Y

-21.2%

Updated

26 Jun, 2022

Data

Company Financials +
SBRA fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance0/6
Financial Health2/6
Dividends3/6

SBRA Stock Overview

As of March 31, 2022, Sabra’s investment portfolio included 416 real estate properties held for investment.

Sabra Health Care REIT Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Sabra Health Care REIT
Historical stock prices
Current Share PriceUS$14.67
52 Week HighUS$19.02
52 Week LowUS$11.44
Beta1.42
1 Month Change5.69%
3 Month Change0.55%
1 Year Change-21.21%
3 Year Change-25.50%
5 Year Change-39.13%
Change since IPO-9.44%

Recent News & Updates

May 27

Sabra: Strong, Steady Dividend, But Also Needs Capacity Building

SBRA has been able to carry forward its four-year average yield of 9 percent through a current yield of 8.6 percent. SBRA has a habit of paying dividends beyond its earnings. To change that, SBRA needs to invest in inorganic growth, and creating provision for further capacity building.

Shareholder Returns

SBRAUS REITsUS Market
7D4.6%6.5%6.6%
1Y-21.2%-8.6%-18.4%

Return vs Industry: SBRA underperformed the US REITs industry which returned -8.6% over the past year.

Return vs Market: SBRA underperformed the US Market which returned -18.4% over the past year.

Price Volatility

Is SBRA's price volatile compared to industry and market?
SBRA volatility
SBRA Average Weekly Movement5.9%
REITs Industry Average Movement4.9%
Market Average Movement8.1%
10% most volatile stocks in US Market16.6%
10% least volatile stocks in US Market3.2%

Stable Share Price: SBRA is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: SBRA's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
201042Rick Matroshttps://www.sabrahealth.com

As of March 31, 2022, Sabra’s investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (“Senior Housing - Leased”), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (“Senior Housing - Managed”), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra’s real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada.

Sabra Health Care REIT Fundamentals Summary

How do Sabra Health Care REIT's earnings and revenue compare to its market cap?
SBRA fundamental statistics
Market CapUS$3.39b
Earnings (TTM)-US$106.10m
Revenue (TTM)US$401.18m

8.4x

P/S Ratio

-31.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SBRA income statement (TTM)
RevenueUS$401.18m
Cost of RevenueUS$144.12m
Gross ProfitUS$257.06m
Other ExpensesUS$363.16m
Earnings-US$106.10m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.46
Gross Margin64.08%
Net Profit Margin-26.45%
Debt/Equity Ratio70.1%

How did SBRA perform over the long term?

See historical performance and comparison

Dividends

8.2%

Current Dividend Yield

103%

Payout Ratio
We’ve recently updated our valuation analysis.

Valuation

Is SBRA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SBRA?

Other financial metrics that can be useful for relative valuation.

SBRA key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue14.2x
Enterprise Value/EBITDA24.4x
PEG Ration/a

Price to Sales Ratio vs Peers

How does SBRA's PS Ratio compare to its peers?

SBRA PS Ratio vs Peers
The above table shows the PS ratio for SBRA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average8.8x

Price-To-Sales vs Peers: SBRA is good value based on its Price-To-Sales Ratio (8.4x) compared to the peer average (8.8x).


Price to Earnings Ratio vs Industry

How does SBRA's PE Ratio compare vs other companies in the U.S. REITs Industry?

Price-To-Sales vs Industry: SBRA is expensive based on its Price-To-Sales Ratio (8.4x) compared to the US REITs industry average (5.9x)


Price to Sales Ratio vs Fair Ratio

What is SBRA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SBRA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio8.4x
Fair PS Ratio6x

Price-To-Sales vs Fair Ratio: SBRA is expensive based on its Price-To-Sales Ratio (8.4x) compared to the estimated Fair Price-To-Sales Ratio (6x).


Share Price vs Fair Value

What is the Fair Price of SBRA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SBRA ($14.67) is trading below our estimate of fair value ($42.66)

Significantly Below Fair Value: SBRA is trading below fair value by more than 20%.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate SBRA's PEG Ratio to determine if it is good value.


Discover undervalued companies

Future Growth

How is Sabra Health Care REIT forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

Future Growth Score

3/6

Future Growth Score 3/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


12.9%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SBRA is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).

Earnings vs Market: SBRA is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: SBRA is expected to become profitable in the next 3 years.

Revenue vs Market: SBRA's revenue (6.2% per year) is forecast to grow slower than the US market (8.4% per year).

High Growth Revenue: SBRA's revenue (6.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: SBRA's Return on Equity is forecast to be low in 3 years time (5.7%).


Discover growth companies

Past Performance

How has Sabra Health Care REIT performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-32.9%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: SBRA is currently unprofitable.

Growing Profit Margin: SBRA is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: SBRA is unprofitable, and losses have increased over the past 5 years at a rate of 32.9% per year.

Accelerating Growth: Unable to compare SBRA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SBRA is unprofitable, making it difficult to compare its past year earnings growth to the REITs industry (69.5%).


Return on Equity

High ROE: SBRA has a negative Return on Equity (-3.16%), as it is currently unprofitable.


Discover strong past performing companies

Financial Health

How is Sabra Health Care REIT's financial position?

Financial Health Score

2/6

Financial Health Score 2/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: SBRA's short term assets ($216.9M) exceed its short term liabilities ($118.3M).

Long Term Liabilities: SBRA's short term assets ($216.9M) do not cover its long term liabilities ($2.4B).


Debt to Equity History and Analysis

Debt Level: SBRA's net debt to equity ratio (69.1%) is considered high.

Reducing Debt: SBRA's debt to equity ratio has reduced from 119.8% to 70.1% over the past 5 years.

Debt Coverage: SBRA's debt is not well covered by operating cash flow (14.9%).

Interest Coverage: SBRA's interest payments on its debt are not well covered by EBIT (0.4x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Sabra Health Care REIT current dividend yield, its reliability and sustainability?

Dividend Score

3/6

Dividend Score 3/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


8.18%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: SBRA's dividend (8.18%) is higher than the bottom 25% of dividend payers in the US market (1.57%).

High Dividend: SBRA's dividend (8.18%) is in the top 25% of dividend payers in the US market (4.24%)


Stability and Growth of Payments

Stable Dividend: SBRA's dividend payments have been volatile in the past 10 years.

Growing Dividend: SBRA's dividend payments have fallen over the past 10 years.


Earnings Payout to Shareholders

Earnings Coverage: With its high payout ratio (102.9%), SBRA's dividend payments are not well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: At its current cash payout ratio (79%), SBRA's dividend payments are covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

5.8yrs

Average management tenure


CEO

Rick Matros (67 yo)

12.08yrs

Tenure

US$6,091,584

Compensation

Mr. Richard K. Matros, also known as Rick, is Director of INSPIRIS, Inc. He is Chairman, President & CEO of Sabra Health Care REIT, Inc. from November 04, 2010. He is Director of CareMeridian, LLC. He is D...


CEO Compensation Analysis

Compensation vs Market: Rick's total compensation ($USD6.09M) is about average for companies of similar size in the US market ($USD6.88M).

Compensation vs Earnings: Rick's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: SBRA's management team is seasoned and experienced (5.8 years average tenure).


Board Members

Experienced Board: SBRA's board of directors are considered experienced (4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7%.


Top Shareholders

Company Information

Sabra Health Care REIT, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Sabra Health Care REIT, Inc.
  • Ticker: SBRA
  • Exchange: NasdaqGS
  • Founded: 2010
  • Industry: Health Care REITs
  • Sector: Real Estate
  • Implied Market Cap: US$3.388b
  • Shares outstanding: 230.95m
  • Website: https://www.sabrahealth.com

Number of Employees


Location

  • Sabra Health Care REIT, Inc.
  • 18500 Von Karman Avenue
  • Suite 550
  • Irvine
  • California
  • 92612
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/26 00:00
End of Day Share Price2022/06/24 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.